Cancer Genomics [NEW TOPIC PAGE]

Main|Search|PHGKB






Last Posted: Mar 29, 2018

---

• Approvals in 2017: gene therapies and site-agnostic indications.  
  Blumenthal Gideon M et al. Nature reviews. Clinical oncology 2018 Mar (3) 127-128
• Comment on 'Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study'.  
  Dankner Matthew, et al. British journal of cancer 2018 3
• Reply to `Comment on `Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study''.  
  Shinozaki Eiji, et al. British journal of cancer 2018 3
• Genetic Landscape of Acute Myeloid Leukemia Interrogated by Next-generation Sequencing: A Large Cancer Center Experience.  
  Hussaini Mohammad Omar et al. Cancer genomics & proteomics 15(2) 121-126
• The genomic landscape of pediatric cancers  
  MassGenomics, Blog Mar 2018
• Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations.  
  Allegretti Matteo et al. Journal of experimental & clinical cancer research : CR 2018 Mar 37(1) 47

more